Predictors of epilepsy surgery outcome: a meta-analysis C Tonini, E Beghi Epilepsy Research 62, 75- 87, 2004 | 409 | 2004 |
Dose-dependent teratogenicity of valproate in mono-and polytherapy: an observational study T Tomson, D Battino, E Bonizzoni, J Craig, D Lindhout, E Perucca, ... Neurology 85 (10), 866-872, 2015 | 184 | 2015 |
Antiepileptic drugs and intrauterine death: a prospective observational study from EURAP T Tomson, D Battino, E Bonizzoni, JJ Craig, D Lindhout, E Perucca, ... Neurology 85 (7), 580-588, 2015 | 86 | 2015 |
Hyperbaric oxygen treatment: the influence on the hippocampal superoxide dismutase and Na+, K+-ATPase activities in global cerebral ischemia-exposed rats. J Mrsić-Pelcić, G Pelcić, D Vitezić, I Antoncić, T Filipović, A Simonić, ... Neurochemistry international 44 (8), 585-594, 2004 | 77 | 2004 |
Is there a reason for concern or is it just hype?–A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars A Inotai, CPJ Prins, M Csanádi, D Vitezic, C Codreanu, Z Kaló Expert opinion on biological therapy 17 (8), 915-926, 2017 | 66 | 2017 |
Erectile dysfunction: oral pharmacotherapy options. D Vitezic, JM Pelcic International journal of clinical pharmacology and therapeutics 40 (9), 393-403, 2002 | 56 | 2002 |
Accidental plant poisoning with Colchicum autumnale: Report of two cases N Brncic, I Viskovic, R Peric, A Dirlic, D Vitezic Croatian Medical Journal 42 (6), 673-675, 2001 | 51 | 2001 |
Key learning outcomes for clinical pharmacology and therapeutics education in Europe: a modified Delphi study DJ Brinkman, J Tichelaar, LB Mokkink, T Christiaens, R Likic, ... Clinical Pharmacology & Therapeutics 104 (2), 317-325, 2018 | 50 | 2018 |
Lithium treatments: single and multiple daily dosing D Ljubicic, M Letica-Crepulja, D Vitezic, IL Bistrovic, R Ljubicic The Canadian Journal of Psychiatry 53 (5), 323-331, 2008 | 25 | 2008 |
Policy practices to maximise social benefit from biosimilars A Inotai, M Csanádi, D Vitezic, I Francetic, T Tesar, T Bochenek, ... | 24 | 2017 |
Hrvatska strategija borbe protiv Alzheimerove bolesti i drugih demencija-prijedlog nacrta uz nadopune N Mimica, M Kušan Jukić, P Presečki, M Ivičić, M Braš, L Vrbić, M Boban, ... Medix 21 (117), 111-118, 2015 | 24 | 2015 |
The influence of MK-801 on the hippocampal free arachidonic acid level and Na+, K+-ATPase activity in global cerebral ischemia-exposed rats J Mršić-Pelčić, G Župan, D Maysinger, G Pelčić, D Vitezić, A Simonić Progress in Neuro-Psychopharmacology and Biological Psychiatry 26 (7-8 …, 2002 | 23 | 2002 |
Effects of nimodipine, felodipine and amlodipine on electroconvulsive shock-induced amnesia in the rat G Zupan, D Vitezic European Journal of Pharmacology 310, 103-106, 1996 | 23 | 1996 |
Pharmacodynamics and pharmacokinetics in the elderly Z DURAKOVIĆ, D VITEZIĆ Periodicum biologorum 115 (4), 517-520, 2013 | 22 | 2013 |
A risk-benefit assessment of sildenafil in the treatment of erectile dysfunction D Vitezic Drug safety 24 (4), 255-265, 2001 | 21 | 2001 |
Naphazoline nasal-drops intoxication in children D Vitezić, V Rožmanić, J Franulović, V Ahel, D Matešić Arhiv za higijenu rada i toksikologiju 45 (1), 25-29, 1994 | 21 | 1994 |
The effects of problem-based learning integration in a course on rational drug use: a comparative study between two Croatian medical schools R Likic, D Vitezic, S Maxwell, O Polasek, I Francetic European journal of clinical pharmacology 65, 231-237, 2009 | 18 | 2009 |
Lijekovi i trudnoća V Erdeljić Turk, D Vitezić Medicus 26 (1 Farmakovigilancija), 23-36, 2017 | 17 | 2017 |
Benefits of investment into modern medicines in Central–Eastern European countries A Inotai, G Petrova, D Vitezic, Z Kalo Expert Review of Pharmacoeconomics & Outcomes Research 14 (1), 71-79, 2014 | 17 | 2014 |
NA+, K+-ATPase activity in the brain of the rats with kainic acid-induced seizures: influence of lamotrigine. D Vitezić, JM Pelcić, G Zupan, M Vitezić, D Ljubicić, A Simonić Psychiatria Danubina 20 (3), 269-276, 2008 | 17 | 2008 |